ES8601131A1 - Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina. - Google Patents

Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina.

Info

Publication number
ES8601131A1
ES8601131A1 ES540172A ES540172A ES8601131A1 ES 8601131 A1 ES8601131 A1 ES 8601131A1 ES 540172 A ES540172 A ES 540172A ES 540172 A ES540172 A ES 540172A ES 8601131 A1 ES8601131 A1 ES 8601131A1
Authority
ES
Spain
Prior art keywords
methylpiperidine
trans
metoxifenoxi
fluorofenil
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES540172A
Other languages
English (en)
Other versions
ES540172A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrosan ApS
Original Assignee
Ferrosan ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan ApS filed Critical Ferrosan ApS
Publication of ES8601131A1 publication Critical patent/ES8601131A1/es
Publication of ES540172A0 publication Critical patent/ES540172A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

METODO PARA PREPARAR (-)-TRANS-4-(4-FLUOROFENIL)-3-(4-METOXIFENOXI)METILPIPERIDINA. SE 1-DEMETILA EL COMPUESTO (-)TRANS-4-(4-FLUOROFENIL)-3-(4-METOXIFENOXI)-METIL-METIL-PIPERIDINA HACIENDO REACCIONAR LA BASE LIBRE CON FENILETER DE ACIDO CLOROFORMICO Y DESPUES CON UNA BASE. LA PRIMERA ETAPA ES EN FRIO Y LA SEGUNDA A TEMPERATURA DE REFLUJO. LA BASE ES PREFERENTEMENTE EL MONOMETILETER DE ETILENO GLICOL BASICO.
ES540172A 1984-02-07 1985-02-06 Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina. Granted ES540172A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/577,844 US4585777A (en) 1984-02-07 1984-02-07 (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT

Publications (2)

Publication Number Publication Date
ES8601131A1 true ES8601131A1 (es) 1985-11-16
ES540172A0 ES540172A0 (es) 1985-11-16

Family

ID=24310381

Family Applications (1)

Application Number Title Priority Date Filing Date
ES540172A Granted ES540172A0 (es) 1984-02-07 1985-02-06 Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina.

Country Status (12)

Country Link
US (1) US4585777A (es)
EP (1) EP0152273B1 (es)
JP (1) JPS60181071A (es)
AT (1) ATE46146T1 (es)
CA (1) CA1246082A (es)
DE (1) DE3572807D1 (es)
DK (1) DK53285A (es)
ES (1) ES540172A0 (es)
FI (1) FI850449A7 (es)
GR (1) GR850309B (es)
IE (1) IE850286L (es)
NO (1) NO850444L (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
GB9700690D0 (en) 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
JP2002514222A (ja) * 1997-05-29 2002-05-14 スミスクライン・ビーチャム・コーポレイション 新規方法
AU2002301956B2 (en) * 1997-06-10 2006-02-09 Synthon B.V. 4-phenylpiperidine compounds
EE03970B1 (et) * 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
EP1280775A1 (en) 2000-05-12 2003-02-05 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
EP1301508A1 (en) * 2000-07-17 2003-04-16 Smithkline Beecham Plc Novel processes for the preparation of 4-phenylpiperidine derivatives
AU2001211337A1 (en) * 2000-10-06 2002-04-15 Smithkline Beecham Plc Process for the preparation of aryl-piperidine carbinols and intermediates thereof
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
US6930186B2 (en) * 2001-06-13 2005-08-16 Teva Pharmacetical Industries Ltd. Process for the preparation of paroxetine substantially free of alkoxy impurities
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
JP5647519B2 (ja) 2007-09-13 2014-12-24 コンサート ファーマシューティカルズ インコーポレイテッド 重水素化カテコールおよびベンゾ［ｄ］［１，３］ジオキソールおよびその誘導体の合成

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds

Also Published As

Publication number Publication date
EP0152273A3 (en) 1986-12-30
DK53285D0 (da) 1985-02-06
ATE46146T1 (de) 1989-09-15
JPS6135176B2 (es) 1986-08-12
FI850449A0 (fi) 1985-02-04
NO850444L (no) 1985-08-08
CA1246082A (en) 1988-12-06
IE850286L (en) 1985-08-07
EP0152273A2 (en) 1985-08-21
US4585777A (en) 1986-04-29
JPS60181071A (ja) 1985-09-14
FI850449L (fi) 1985-08-08
EP0152273B1 (en) 1989-09-06
GR850309B (es) 1985-06-05
DE3572807D1 (en) 1989-10-12
DK53285A (da) 1985-08-08
ES540172A0 (es) 1985-11-16
FI850449A7 (fi) 1985-08-08

Similar Documents

Publication Publication Date Title
ES540172A0 (es) Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina.
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
ATE44528T1 (de) Arzneimittel mit antipsychotischer wirkung.
JPS51115478A (en) Piperidine derivatives acid addidion salt and optical isomer
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
DK0506778T3 (da) Substituerede 4-phenyl-4-piperidincarboxamider med både lokal anæstetisk og analgetisk virkning samt fremgangsmåder til deres fremstilling
UA19149A (uk) Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу
ES472588A1 (es) Un procedimiento para la preparacion de un nuevo derivado deacido cicloalquilidenmetilfenilacetico
BG44204A3 (en) Method for preparing of 2- oxyindol derivatives
IT8548267A0 (it) Derivati di i,4-diidropiridina e suoi sali, procedimento per produrli e composizione farmaceutica cheli contiene
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
SE7702041L (sv) Forfarande for framstellning av 2,3-substituerade, 5,6-kondenserade 4(2h)-aminoalkoxi-pyranoner med hypotensiv, anti-ischemi-och antihostverkan
NO864635D0 (no) Nye krystallinske salter av aryloksyfenolaminer og deres fremstilling.
NO853782L (no) Fremgangsm¨te for fremstilling av terapeutisk aktive furo- pyridinderivater.
AU581855B2 (en) 1-(4'-alkylsulphonylphenyl)-2-amino-1, 3-propanediol n-substituted derivatives
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
DK412985A (da) Prolinforbindelse og farmaceutisk praeparat indeholdende forbindelsen
ES2046528T3 (es) Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos.
DE3687100D1 (de) Clavamderivate, herstellung und zwischenprodukte.
IT1210926B (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
ES493888A0 (es) Un metodo de preparar derivados de piperidina
DK159847C (da) Salte af 5-cyanopyridin-2-diazohydroxid
GB1102357A (en) Piperidine derivatives and process for their production
ES462071A1 (es) Procedimiento de preparacion de n-2,6-diclorofenil-2-amino- pirimidina.